Sentences with phrase «name of the generic drug»

Not exact matches

For instance, a ProPublica analysis of Medicare's Part D prescription drug program found that doctors who received more industry money were also more likely to prescribe brand name, rather than cheaper generic, drugs.

In general, generics are a wonderful thing — they're a lower - cost alternative to expensive, brand - name versions of drugs.

The article described how an internal investigation conducted by a company executive, Dinesh Thakur, who went on to become a whistleblower, reported appalling deceit: Ranbaxy scientists substituted cheaper, lower - quality ingredients in place of better ingredients, manipulated test parameters, and even bought brand - name drugs and used them in place of their own generics to win FDA approval.

After generic drug maker Actavis bought Allergan last year, it took the name of the specialty pharmaceutical company; the reinvented Allergan then turned around and sold its legacy generic business to Teva Pharmaceutical Industries (TEVA) in July.

Contrary to Clinton's assertion that the patient «has to take a brand - name drug,» the patient has for the last 16 years had the option to take a much cheaper generic version of it.

The higher costs have led to rationing of dwindling supplies of the less expensive generic drugs to avoid purchasing the more expensive name brand treatments.

Headline updated to note that the generic name of the anti-overdose drug is naloxone.

That's an even rarer feat for a generic drug maker such as Mylan, which makes most of its revenue not on brand - name drugs, but on cheaper, equivalent versions of other companies» branded medications.

Pharmacies used to be able to charge 50 % or more of the price of a name - brand drug for its generic equivalent.

An Indian generic drug company on Monday urged a federal appeals court to reconsider a recent decision that revived a patent infringement case against Google LLC, saying the ruling could spur «vexatious lawsuits» by makers of brand - name pharmaceutical products.

For a generic drug manufacturer to get the U.S. Food and Drug Administration's (FDA) stamp of approval, they must prove it is pharmaceutically equal to the name - brand versdrug manufacturer to get the U.S. Food and Drug Administration's (FDA) stamp of approval, they must prove it is pharmaceutically equal to the name - brand versDrug Administration's (FDA) stamp of approval, they must prove it is pharmaceutically equal to the name - brand version.

Leave all medications and drugs in their original, labelled containers with the name of either the pharmacy that dispensed the medication or the manufacturer of the medication, and have on hand a copy of the original prescription, with both the generic and trade names of the drug.

Drugs cited in Tables 1 through 7 are listed in alphabetical order by generic name; brand names are available from the current Physicians» Desk Reference, 23 USP DI 2001: Drug Information for the Health Care Professional, Volume I, 24 and USP Dictionary of USAN and International Drug Names.25 The reference list is not inclusive of all articles published on the tnames are available from the current Physicians» Desk Reference, 23 USP DI 2001: Drug Information for the Health Care Professional, Volume I, 24 and USP Dictionary of USAN and International Drug Names.25 The reference list is not inclusive of all articles published on the tNames.25 The reference list is not inclusive of all articles published on the topic.

Drug maker Mylan said it will offer a generic version of the life - saving allergy treatment EpiPen for half the list price of the brand - name treatment after it became the center of a national controversy over skyrocketing drug priDrug maker Mylan said it will offer a generic version of the life - saving allergy treatment EpiPen for half the list price of the brand - name treatment after it became the center of a national controversy over skyrocketing drug pridrug prices.

As prescription drug prices — both brand - name and generic — continue to rise, a number of bipartisan proposals to combat the issue have been put on the table.

«A civil war has broken out among the most powerful players in the pharmaceutical industry — including brand - name and generic drug makers, and even your local pharmacists — with each blaming others for the rising price of medicine.»

To avoid paying # 400 a month for private prescriptions of the brand - name drug Truvada, growing numbers are buying generic versions from online pharmacies in India and Swaziland for # 40 a month, through a UK website called I Want PrEP Now.

Generic low - cost versions of the drugs are available — Walmart sells a month's supply of low - dose lovastatin for $ 4 — but many consumers choose costlier brand name options.

And generic versions of drugs have been known to act differently from name - brand products (see accompanying story.)

The vast majority, 81, were generic versions of brand - name drugs on which Cetero scientists had often run critical tests to determine whether the copies did, in fact, act the same in the body as the originals.

The decline was due to increased use of generic drugs as some popular brand - name drugs lost patent protection, increases in cost - sharing requirements, and lower spending on new medicines.

Every 6 hours, like clockwork, Seandradh and Al give their boys Cystagon (a trademarked drug with the generic name Cystagon), as well as oversee treatment of other related conditions.

In fact, a 2009 FDA study showed that of 2,070 orally administered generic drug products approved by the agency between 1996 to 2007, generics differ in bioequivalency from brand names, on average, by about 3.5 percent; less than two percent varied by more than 10 percent.

* Eliminate «pay - for - delay» strategies in which a pharmaceutical company with a brand name drug shares profits on that drug with a generic drug manufacturer for the remainder of a patent period, effectively eliminating a patent challenge and competition.

But the growth of e-commerce has flooded the market with a wide range of both brand name and generic drugs.

(That's different from manufacturing a small - molecule generic, which will have the exact chemical structure of the brand - name drug.)

Generics are copies of brand - name drugs that contain identical active ingredients and work the same way in the body.

For example, ninety 10 - mg tablets of generic simvastatin, a drug used to lower cholesterol, sell for around $ 90, while the same amount of Zocor, the brand - name version, costs about $ 400.

Examples of Medicaid fraud include: billing for services not performed, providing unnecessary services, billing for more expensive services, billing for services separately that should legitimately be one billing, billing more than once for the same medical service, dispensing generic drugs but billing for brand name drugs.

The patent on the human form of it expired a while back; this meant that other drug companies could produce it under its generic name, fluoxetine.

Like many drugs, there are a number of names by which Clomipramine can go by, including Anafanil (made by Novartis,) Clomicalm (manufactured by Novartis) or the generic Clomipramine Hydrochloride.

It is an expensive drug under its brand name, but there is a generic equivalent to the human form of the drug (Eldepryl): selegiline hydrochloride.

On an issue of first impression, however, the California Court of Appeals in Conte v. Wyeth, Inc. rejected this traditional view and held that a brand - name manufacturer's duty to warn extends to patients whose prescriptions are filled with the generic version of the drug.

Following the decision, three other courts adopted this minority position that brand - name manufacturers can be liable for injuries caused by the generic version of their drug.

According to the American Osteopathic College of Dermatology, Accutane (generic name: Isotretinoin) is a powerful drug prescribed for severe acne.

• longer periods of protection of data exclusivity protection for brand name drugs to keep generics off the market;

Currently, Canada is the only country that allows brand name pharmaceutical companies to sue generic pharmaceutical companies multiple times on the same patents, adding to the costs and risks of bringing generic drug competition to the Canadian market.

New California Appellate Decision Makes Brand Name Drug Manufacturers Potentially Liable for Injuries Suffered by Consumers of Generic Drugs

Plaintiff May Sue Manufacturer of Name - Brand Prescription Drug for Injury Allegedly Caused by Different Company's Generic Drug, Indiana Injury Lawyer Blog, February 28, 2013 Federal Statute Preempts State Products Liability Lawsuit Over Asbestos Exposure, According to Supreme Court: Kurns v. Railroad Friction Products Corp., Indiana Injury Lawyer Blog, October 18, 2012

Types of medications (including the names of generic and brand drugs) that have been linked to Stevens - Johnson Syndrome: • Anticonvulsants • Antibiotics • Nonsteroidal anti-inflammatory drugs (OTC and prescription) • Drugs with sulfa • Barbiturates • COX - 2 inhibitors • Ibuprofen • Acetaminophens • Allopurinol • Carbamazepine • Phenytoin • Bextra, which Pfizer removed from the market in 2005 because of the SJS risk it posed to users • Children's Advil or Motrin • Tylenol • Aldactone • Septra • Advil • Motrin • Avelox • Prilosec • Neurontin • Coreg • Feldene • Athrotec • Ceclor • Dilantin • Vioxx • Relafen • Celebrex • Levaquin • Depakote • Zantac • Tegretol • Provigil • Zithromax • Trileptal • Zyloprin • Clinoril • Phenytek Dangerous Drugs Severe drug reactions cause tens of thousands of patient deaths in this country each drugs) that have been linked to Stevens - Johnson Syndrome: • Anticonvulsants • Antibiotics • Nonsteroidal anti-inflammatory drugs (OTC and prescription) • Drugs with sulfa • Barbiturates • COX - 2 inhibitors • Ibuprofen • Acetaminophens • Allopurinol • Carbamazepine • Phenytoin • Bextra, which Pfizer removed from the market in 2005 because of the SJS risk it posed to users • Children's Advil or Motrin • Tylenol • Aldactone • Septra • Advil • Motrin • Avelox • Prilosec • Neurontin • Coreg • Feldene • Athrotec • Ceclor • Dilantin • Vioxx • Relafen • Celebrex • Levaquin • Depakote • Zantac • Tegretol • Provigil • Zithromax • Trileptal • Zyloprin • Clinoril • Phenytek Dangerous Drugs Severe drug reactions cause tens of thousands of patient deaths in this country each drugs (OTC and prescription) • Drugs with sulfa • Barbiturates • COX - 2 inhibitors • Ibuprofen • Acetaminophens • Allopurinol • Carbamazepine • Phenytoin • Bextra, which Pfizer removed from the market in 2005 because of the SJS risk it posed to users • Children's Advil or Motrin • Tylenol • Aldactone • Septra • Advil • Motrin • Avelox • Prilosec • Neurontin • Coreg • Feldene • Athrotec • Ceclor • Dilantin • Vioxx • Relafen • Celebrex • Levaquin • Depakote • Zantac • Tegretol • Provigil • Zithromax • Trileptal • Zyloprin • Clinoril • Phenytek Dangerous Drugs Severe drug reactions cause tens of thousands of patient deaths in this country each Drugs with sulfa • Barbiturates • COX - 2 inhibitors • Ibuprofen • Acetaminophens • Allopurinol • Carbamazepine • Phenytoin • Bextra, which Pfizer removed from the market in 2005 because of the SJS risk it posed to users • Children's Advil or Motrin • Tylenol • Aldactone • Septra • Advil • Motrin • Avelox • Prilosec • Neurontin • Coreg • Feldene • Athrotec • Ceclor • Dilantin • Vioxx • Relafen • Celebrex • Levaquin • Depakote • Zantac • Tegretol • Provigil • Zithromax • Trileptal • Zyloprin • Clinoril • Phenytek Dangerous Drugs Severe drug reactions cause tens of thousands of patient deaths in this country each Drugs Severe drug reactions cause tens of thousands of patient deaths in this country each year.

[9] The potential lifelong side effects of this drug were not disclosed within the brand - name manufacturer's nor the mirrored generic manufacturer's warning label.

[16] The SJC considered innovator liability to require such a modification given the certainty that a user of a generic drug will rely on the label fashioned by the brand - name manufacturer and as state law shields failure to warn claims from generic manufacturers, leaving plaintiffs without recourse for their injuries.

Specifically, in Rafferty v. Merck & Co., Inc., [4] the SJC held that plaintiffs who ingest the generic form of a drug may bring failure to warn claims against the brand - name manufacturer of the drug if the brand - name defendant acted recklessly by «intentionally fail [ing] to update the label on its drug while knowing or having reason to know of an unreasonable risk of death or grave bodily injury associated with its use.»

Balancing these competing interests, the court held that, «a brand - name manufacturer that controls the contents of the label on a generic drug owes a duty to consumers of that generic drug not to act in reckless disregard of an unreasonable risk of death or grave bodily injury.»

Relevant to the matter considered by the SJC, the Drug Price Competition and Patent Term Restoration Act, informally known as the «Hatch - Waxman Act» requires the «manufacturer of a generic drug [to] provide its users with a warning label that is identical to the label of the brand - name counterpart.&raDrug Price Competition and Patent Term Restoration Act, informally known as the «Hatch - Waxman Act» requires the «manufacturer of a generic drug [to] provide its users with a warning label that is identical to the label of the brand - name counterpart.&radrug [to] provide its users with a warning label that is identical to the label of the brand - name counterpart.»

In 2010, a physician prescribed Finasteride, the generic version of the brand name drug Proscar, to treat Rafferty's enlarged prostate.

Mr. Simon also recently represented a generic brand drug company in an individual case alleging that the brand name manufacturer had filed false citizens petitions to delay the entry of the generic drug unto the market.

Now, the justices are trying to decide whether generic drug manufacturers can be sued in state court for design defects - especially when the generic version is an exact copy of its brand - name counterpart that the federal government had already approved.

Our pharmaceutical work puts us at the forefront of cutting edge issues, including preemption of medical device and prescription drug claims, the learned intermediary doctrine, comment k, market share liability, and brand name liability for generic use.

Through amendments to both the patent and the food and drug laws, the Act established several practices intended to provide brand - name firms with incentives to innovate while facilitating the marketing of generic pharmaceuticals.